LIMK1 Inhibitors - A Novel, Disease-Modifying Approach for the Treatment of Fragile X Syndrome (Developmental Pathways Funding Scheme - Full Stage) (Joint with Cardiff University and University of Oxford)

StatusActive
Effective start/end date1/05/1930/04/21

Funding

  • Medical Research Council (MR/S005331/1 514413 (UoCardiff)): £219,937.00